Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune Diseases
Joint Authors
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-06-16
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Interleukin-33 (IL-33) is a new cytokine of interleukin-1 family, whose specific receptor is ST2.
IL-33 exerts its functions via its target cells and plays different roles in diseases.
ST2 deletion and exclusion of IL-33/ST2 axis are accompanied by enhanced susceptibility to dominantly T cell-mediated organ-specific autoimmune diseases.
It has been reported that IL-33/ST2 pathway plays a key role in host defense and immune regulation in inflammatory and infectious diseases.
This review focuses on new findings in the roles of IL-33 and ST2 in several kinds of T cell-mediated autoimmune diseases.
American Psychological Association (APA)
Zhao, Qing& Chen, Guangjie. 2014. Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune Diseases. BioMed Research International،Vol. 2014, no. 2014, pp.1-10.
https://search.emarefa.net/detail/BIM-483032
Modern Language Association (MLA)
Zhao, Qing& Chen, Guangjie. Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune Diseases. BioMed Research International No. 2014 (2014), pp.1-10.
https://search.emarefa.net/detail/BIM-483032
American Medical Association (AMA)
Zhao, Qing& Chen, Guangjie. Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune Diseases. BioMed Research International. 2014. Vol. 2014, no. 2014, pp.1-10.
https://search.emarefa.net/detail/BIM-483032
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-483032
